ClinicalTrials.Veeva

Menu

Association Between Testosterone Levels and COPD Severity (COPDTESTO)

H

Hospital Italiano de Buenos Aires

Status

Unknown

Conditions

Chronic Obstructive Pulmonary Disease
Hypogonadism

Study type

Observational

Funder types

Other

Identifiers

Details and patient eligibility

About

The Aims of the study are estimate the association between the severity of COPD and free testosterone level and the prevalence of hypogonadism in adult men with stable COPD

Enrollment

150 estimated patients

Sex

Male

Ages

45+ years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • Adults Men ≥ 45 years
  • COPD defined according to clinical diagnosis and spirometry American thoracic society ( ATS) criteria
  • Stable COPD without recent acute exacerbation (less than 2 weeks)

Exclusion criteria

  • Refusal to participate or informed consent process
  • Those who are under treatment with testosterone replacement or anti-androgens
  • Comorbidities: Cirrhosis, Alcoholism, cryptorchidism, panhypopituitarism, Pituitary adenoma.
  • Orchiectomy
  • Systemic glucocorticoids (equivalent dose ≥ 4 mg of prednisone in the last 3 weeks).
  • Relative and absolute contraindications for spirometry.

Trial contacts and locations

1

Loading...

Central trial contact

Joaquin Maritano Furcada, MD; Horacio M Castro, MD

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2025 Veeva Systems